Pull it straight! 603516, 5 boards in 6 days! Some pharmaceutical stocks once rose more than 50%

The concept of liquid-cooled servers has changed significantly, and Chunzhong Technology(603516) has gone out of 5 boards in 6 days. Douyin concept stocks strengthened at the beginning of the session, with online and offline(300959) trading daily limit of 20 centimeters.
On September 16, the three major A-share indexes opened slightly higher and remained volatile after the opening.
On the market, precious metals, coal, auto parts, catering and tourism sectors strengthened, while agriculture, real estate and other sectors weakened.
In terms of Hong Kong stocks, the Hang Seng Index and the Hang Seng Technology Index are both red. Yaojie Ankang-Bonce rose more than 50% in intraday trading, andKaisa Group once rose nearly 30%. Ideal Automobileand Meituan rose nearly 3%, while BaiduGroup, Xiaomi Group, Alibaba, etc. rose more than 1%.
strengthened At the beginning of the market, the concept of liquid-cooled servers strengthened again. Chunzhong Technology went out of 6 days and 5 boards. Runhe Materials, Yinlun, Zhongshi Technology, Dayuan Pump, Shuguang Digital Innovation, etc. followedsuit.
On the news front, Nvidiais pushing upstream suppliers to develop a type of water-cooled cooling component called MLCP (Microchannel Water Cooling Board) to cope with the increasing heat generation of AI GPU chips with intergenerational replacement. The unit price is three to five times that of existing cooling solutions.
Chunzhong Technology recently issued a stock trading risk warning announcement, saying that it has recently paid attention to the market's high attention to the liquid-cooled server concept sector. The company's business does not involve the production and manufacturing of liquid-cooled servers, and only participates in testing links such as liquid-cooled test platforms. In the first half of 2025, this business generated no revenue, and inventory impairment reserves and credit impairment losses totaled 10.7865 million yuan in the semi-annual period. This business cooperation was subsequently affected by many factors such as customer product iteration and adaptation testing, and there was a risk that business progress would seriously fall short of expectations.
Douyin concept stocks strengthened at the beginning of the session, with a daily limit of 20 centimeters online and offline. The stock has been trading for two consecutive days.Provincial Guangzhou Group's daily limit rose, followed by Blue Cursor, Tianlong Group, Easy Point Tianxia, Gravity Media, and Youwang Technology (rights protection).
Online and offline is a mobile information serviceprovider. The company's change of ownership was finally implemented recently. On the evening of September 8, online and offline announced that Wang Kun, Men Qingjuan and Wuxi Junmao had agreed to Shenlei Technology to transfer the company's shares. The confirmation opinion issued by the Shenzhen Stock Exchange has been obtained, and the transfer registration procedures have been completed with China Securities Depository and Clearing Co., Ltd., and the" Securities Transfer Registration Confirmation Form "has been obtained. At this point, the controlling shareholder of the company was changed to Shenlei Technology, and the actual controllers were changed to Xia Jun and Li Wei.
Humanoid robotconcept stocks surged and rose, beating the dailylimit of Electronics. Wanxiang Qianchao, Nanshan Zhishang, Alid,etc. were among the top gainers.On the news front, the appearance patent for the "performancerobot" applied by Hangzhou Yushu Technology Co., Ltd. was authorized.
stock pharmaceutical stocks rose intraday. Pharmaceutical Pharmaceutical Ankang-B once rose more than 50%, and Tongyuankang Pharmaceuticals-B and Wei Lizhibo-B were among the top gainers.
On the news front, Wujie Ankang has been transferred to the Hong Kong Stock Connect list, effective from September 8. On September 10, Wujie Ankang announced that the company's core product, tiengotinib combined with fulvestrant, is used for the treatment of hormone receptor positive (HR+) and human epidermal growth factor receptor 2 negative or low expression (HER2-). The Phase II clinical trial of relapsed or metastatic breast cancer has obtained clinical implicit approval from the State Food and Drug Administration on September 10, 2025.
Kaisa Group once rose nearly 30%. On September 15,Kaisa Group announced that all conditions for its overseas debt restructuring had been met and the restructuring plan had been fully effective.
The announcement shows that Kaisa Group has issued 6 new notes and 8 mandatory convertible bonds totaling approximately US$13.372 billion to qualified creditors in accordance with the restructuring plan, taking into account the choices of different terms and returns. The mandatory convertible bonds give creditors the opportunity to convert shares in the future.The new notes and mandatory convertible bonds are expected to be listed on the Singapore Stock Exchange on September 16.